172 related articles for article (PubMed ID: 26536105)
21. Direct comparison of the pharmacodynamics of four antifungal drugs in a mouse model of disseminated candidiasis using microbiological assays of serum drug concentrations.
Maki K; Holmes AR; Watabe E; Iguchi Y; Matsumoto S; Ikeda F; Tawara S; Mutoh S
Microbiol Immunol; 2007; 51(11):1053-9. PubMed ID: 18037782
[TBL] [Abstract][Full Text] [Related]
22. Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
Agudelo M; Rodriguez CA; Zuluaga AF; Vesga O
Int J Antimicrob Agents; 2015 Feb; 45(2):161-7. PubMed ID: 25481459
[TBL] [Abstract][Full Text] [Related]
23. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
[TBL] [Abstract][Full Text] [Related]
24. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
[TBL] [Abstract][Full Text] [Related]
25. In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis.
Sinnollareddy MG; Roberts MS; Lipman J; Lassig-Smith M; Starr T; Robertson T; Peake SL; Roberts JA
Antimicrob Agents Chemother; 2016 Feb; 60(2):827-32. PubMed ID: 26596947
[TBL] [Abstract][Full Text] [Related]
26. Comparison of In Vivo Pharmacokinetics and Pharmacodynamics of Vancomycin Products Available in Korea.
Kim HK; Choi SM; Kang G; Park KH; Lee DG; Park WB; Rhee SJ; Lee S; Jung SI; Jang HC
Yonsei Med J; 2020 Apr; 61(4):301-309. PubMed ID: 32233172
[TBL] [Abstract][Full Text] [Related]
27. Plasma and tissue concentrations of fluconazole and their correlation to breakpoints.
Pittrow L; Penk A
Mycoses; 1997; 40(1-2):25-32. PubMed ID: 9260478
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.
Louie A; Drusano GL; Banerjee P; Liu QF; Liu W; Kaw P; Shayegani M; Taber H; Miller MH
Antimicrob Agents Chemother; 1998 May; 42(5):1105-9. PubMed ID: 9593135
[TBL] [Abstract][Full Text] [Related]
29. Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection.
Costa-de-Oliveira S; Miranda IM; Silva-Dias A; Silva AP; Rodrigues AG; Pina-Vaz C
Antimicrob Agents Chemother; 2015 Jul; 59(7):4289-92. PubMed ID: 25845879
[TBL] [Abstract][Full Text] [Related]
30. Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia.
Gumbo T; Drusano GL; Liu W; Kulawy RW; Fregeau C; Hsu V; Louie A
Antimicrob Agents Chemother; 2007 Mar; 51(3):968-74. PubMed ID: 17194830
[TBL] [Abstract][Full Text] [Related]
31. Ascorbic acid decreases the antifungal effect of fluconazole in the treatment of candidiasis.
Wang Y; Jia XM; Jia JH; Li MB; Cao YY; Gao PH; Liao WQ; Cao YB; Jiang YY
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):e40-6. PubMed ID: 19413603
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of fluconazole after a single oral dose and administration in drinking water in cockatiels (Nymphicus hollandicus).
Ratzlaff K; Papich MG; Flammer K
J Avian Med Surg; 2011 Mar; 25(1):23-31. PubMed ID: 21657184
[TBL] [Abstract][Full Text] [Related]
33. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers.
Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N
Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294
[TBL] [Abstract][Full Text] [Related]
34. Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.
Astvad KMT; Meletiadis J; Whalley S; Arendrup MC
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760893
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Ghannoum MA; Kim HG; Long L
J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters.
Lakota EA; Bader JC; Ong V; Bartizal K; Miesel L; Andes DR; Bhavnani SM; Rubino CM; Ambrose PG; Lepak AJ
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848022
[TBL] [Abstract][Full Text] [Related]
37. Comparison of fluconazole renal penetration levels in healthy and Candida albicans-infected Wistar rats.
Azeredo FJ; de Araújo BV; Haas SE; Torres B; Pigatto M; de Andrade C; Dalla Costa T
Antimicrob Agents Chemother; 2012 Nov; 56(11):5852-7. PubMed ID: 22948869
[TBL] [Abstract][Full Text] [Related]
38. [In vivo and in vitro antifungal activity of fluconazole].
Kawasaki K; Matsumura Y; Ogawa M; Tsuji A; Matsunaga T; Goto S
Jpn J Antibiot; 1991 May; 44(5):552-61. PubMed ID: 1880935
[TBL] [Abstract][Full Text] [Related]
39. Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.
Petraitiene R; Petraitis V; Kelaher AM; Sarafandi AA; Mickiene D; Groll AH; Sein T; Bacher J; Walsh TJ
Antimicrob Agents Chemother; 2005 May; 49(5):2084-92. PubMed ID: 15855534
[TBL] [Abstract][Full Text] [Related]
40. High purity amphotericin B.
Cleary JD; Chapman SW; Swiatlo E; Kramer R
J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
